Oral Semaglutide
Brands: Ozempic · Rybelsus · Semaglutide
1 active makers
soon
soon
soon
soon
US acquisition costNADAC · per unit
Average across 5 priced NDCs. A benchmark of pharmacy acquisition cost — not a retail quote.
Medicaid dispensing volumeSDUD · per quarter
Prescriptions dispensed under Medicaid (fee-for-service + managed care), summed nationally. The closest free proxy to sales volume — Medicaid only, not all-payer.
Who makes it1 active · 0 exited
US labelers as registered with FDA. Repackagers relabel another company's product; share* is of listed packages, not sales.
| Labeler | Type | Packages | Status |
|---|---|---|---|
| Novo Nordisk | unknown | 8 | SUPPLYING |
Regulatory & supply eventsFDA · US
Shortages, recalls, and registration changes attached to this drug concept.
- Jun 4, 2026RESOLVEDShortage resolved: Semaglutide Tablet (Novo Nordisk, Inc.)
Semaglutide Tablet — reported in shortage by Novo Nordisk, Inc.. Therapeutic category: Endocrinology/Metabolism.
- Jun 4, 2026SHORTAGEDrug shortage: Semaglutide Tablet (Novo Nordisk, Inc.)
Semaglutide Tablet — reported in shortage by Novo Nordisk, Inc.. Therapeutic category: Endocrinology/Metabolism.
- Mar 15, 2021RECALLRecall (Class II): Rybelsus (semaglutide) Tablets 7 mg Once daily Each tablet contains 7 mg semaglutide 30 tablets 3 blister packs. Each p…
CGMP Deviations: Intermittent exposure to temperature excursion during storage. — Recalling firm: Cardinal Health Inc. — FL, GA, SC
Pill